Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma
Clinical trial NCT03976102 · COMPLETED
Trial details
- NCT number
- NCT03976102
- Sponsor
- Dr. Reddy's Laboratories Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-15
- Primary completion
- 2022-09-28
- Enrollment
- 317
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.